Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice

The presence of lymph node metastases is a well-studied prognostic factor for cutaneous melanoma. Characterization of melanoma lymph node metastases and their association with survival in multiple, large observational studies has led to recognition of the following high-risk features: quantity of ly...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Kristen E. Rhodin, Denisse Porras Fimbres, Danielle N. Burner, Shayna Hollander, Margaret H. O’Connor, Georgia M. Beasley
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Subjects:	melanoma lymph nodes metastasis clinical trials immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1021057/full